DUREZOL

This brand name is authorized in United States. It is also authorized in Canada, Ecuador.

Active ingredients

The drug DUREZOL contains one active pharmaceutical ingredient (API):

1	Difluprednate UNII S8A06QG2QE - DIFLUPREDNATE
	Difluprednate is a topical corticosteroid indicated for the treatment of inflammation and pain associated with ocular surgery. Corticosteroids inhibit the inflammatory response to a variety of inciting agents and may delay or slow healing. There is no generally accepted explanation for the mechanism of action of ocular corticosteroids.
	Read more about Difluprednate

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DUREZOL Emulsion	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D07AC19	Difluprednate	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC19

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02415534
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	648-MEE-0115
US	FDA, National Drug Code	0065-9240